MGCD0103 (Mocetinostat)
Référence MBS385124-50mg
Conditionnement : 50mg
Marque : MyBiosource
MGCD0103 (Mocetinostat) Inhibitor
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS385124MGCD0103 (Mocetinostat) is a benzamide histone deacetylase inhibitor by inhibiting mainly histone deacetylase 1 (HDAC1), but also HDAC2, HDAC3, and HDAC11. More details
Product Overview
Online Datasheet in PDFProduct Name
MGCD0103 (Mocetinostat), Inhibitor
Full Product Name
MGCD0103 (Mocetinostat)
Product Synonym Names
MGCD-0103
Form/Format
Powder
Purity/Purification
>98%
Concentration
0.1 mM: 25.23 mL (1 mg); 126.14 mL (5 mg); 252.27mL (10 mg)
0.5 mM: 5.05 mL (1 mg); 25.23 mL (5 mg); 50.45 mL (10 mg)
1 mM: 2.52 mL (1 mg); 12.61 mL (5 mg); 25.23 mL (10 mg)
5 mM: 0.5 mL (1 mg); 2.52 mL (5 mg); 5.05 mL (10 mg) (lot specific)
0.5 mM: 5.05 mL (1 mg); 25.23 mL (5 mg); 50.45 mL (10 mg)
1 mM: 2.52 mL (1 mg); 12.61 mL (5 mg); 25.23 mL (10 mg)
5 mM: 0.5 mL (1 mg); 2.52 mL (5 mg); 5.05 mL (10 mg) (lot specific)
Preparation and Storage
at -20 degree C 3 years Powder
Molecular Weight
396.4
CAS Number
726169-73-9
Formula
C23H20N6O
SMILES
C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4
Actions
Inhibitor
In Vivo Solvent
30% PEG400/0.5% Tween80/5% propylene glycol
Solubility (DMSO)
13 mg/mL (32.79 mM)
Solubility (Ethanol)
<1 mg/mL (<1 mM)
Solubility (in vivo)
30 mg/mL
Solubility (Water)
<1 mg/mL (<1 mM)
Availability
We cannot ship this item to Switzerland, Italy, Germany, France and Austria.
Product References and Citations for MGCD0103 (Mocetinostat), inhibitor
Mari Ishigami-Yuasa, .et al. Class IIb HDAC Inhibition Enhances the Inhibitory Effect of Am80, a Synthetic Retinoid, in Prostate Cancer, Biol Pharm Bull, 2019, 42, 448-452
Guang Bai, .et al. Chapter 1 - Epigenetic Tools in Chronic Pain Studies, Epigenetics of Chronic Pain, 2019, Pages 1-48
Guang Bai, .et al. Chapter 1 - Epigenetic Tools in Chronic Pain Studies, Epigenetics of Chronic Pain, 2019, Pages 1-48
Other Notes
Small volumes of MGCD0103 (Mocetinostat), inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for MGCD0103 (Mocetinostat) purchase
MBS385124 is an inhibitor targeting MGCD0103 (Mocetinostat).


